PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.4400
-0.0200 (-4.35%)
Aug 14, 2025, 1:37 PM - Market open
PAVmed Market Cap
PAVmed has a market cap or net worth of $7.75 million as of August 14, 2025. Its market cap has decreased by -18.40% in one year.
Market Cap
7.75M
Enterprise Value
14.30M
1-Year Change
-18.40%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $7.75M, a decrease of -95.52%. That is a compound annual growth rate of -29.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 8.10M | 17.39% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |